Spinal Tech

Here are the latest financial reports from orthopedic- and spine-driven device companies.

Smith & Nephew CEO Olivier Bohuon is looking for a merger/acquisition deal, according to a Mass Device report.

The Indian market for orthopedic soft tissue repair and sports medicine exceeded $17 million in 2011, according to the latest from Reportlinker.

RTI Biologics, a provider of orthopedic and other biologic implants, reported quarterly revenues of $45.2 million, a 4 percent increase over the second quarter of 2011.

ArthroCare's second quarter revenue reached $97.1 million, indicated a 0.5 percent increase over the same quarter last year.

Globus Medical, a spinal implant manufacturer, announced the pricing of its initial public offering of more than 8 million shares of Class A common stock at a price of $12 per share.

The Japanese market for orthopedic soft tissue repair and sports medicine exceeded $1 billion in 2011, according to the latest analysis from Research and Markets.

The global spinal device and biologics market is expected to grow at a compound annual growth rate of 6.9 percent until 2015, according to the latest analysis by Reporterlink.

DePuy Synthes Spine has received 510(k) clearance from the FDA for use of its EXPEDIUM, VIPER and VIPER2 Spine Systems on patients with adolescent idiopathic scoliosis.

Symmetry Medical's second quarter revenue reached $102.3 million, representing an 8 percent increase over the same quarter last year.